Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Twelve"'
Publikováno v:
Breast Cancer: Targets and Therapy, Vol 2011, Iss default, Pp 101-111 (2011)
J Menis1, C Twelves21Department of Oncology, University Hospital Santa Maria della Misericordia, Udine, Italy; 2Leeds Cancer Research UK Centre, University of Leeds and St James's Institute of Oncology, Leeds, UKAbstract: Although metastatic breast c
Externí odkaz:
https://doaj.org/article/a5e9b2585b654bbd9e10446da9899e17
Publikováno v:
BMC Proceedings, Vol 3, Iss Suppl 5, p S20 (2009)
Externí odkaz:
https://doaj.org/article/dcd9501a884049dd84d9ad2555fe88e3
Publikováno v:
Breast Cancer: Targets and Therapy, Vol 2012, Iss default, Pp 1-2 (2011)
Menis J, Twelves CEribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancerBreast Cancer (London). 2011;3:101–111.Professor Twelves has received honoraria from Eisai.Original article
Externí odkaz:
https://doaj.org/article/e510c612b4c54587af07e3a197d4c46b
Autor:
Anthoney D, Naik Jay, MacPherson Iain RJ, Crawford Donna, Hartley John M, Hartley Janet A, Saito Tomohisa, Abe Masaichi, Jones Keith, Miwa Masanori, Twelves Christopher, Evans TRJ
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 536 (2012)
Abstract Background A Phase I dose escalation first in man study assessed maximum tolerated dose (MTD), dose-limiting toxicity (DLT) and recommended Phase II dose of TP300, a water soluble prodrug of the Topo-1 inhibitor TP3076, and active metabolite
Externí odkaz:
https://doaj.org/article/dd968165113e4c6389ddd5a67d861719
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 52 (2012)
Abstract Background Herein we present the results of two related investigations. The first study determined if concentrations in breast nipple discharge (ND) of two proteins (urinary plasminogen activator, uPA and its inhibitor, PAI-1) predicted the
Externí odkaz:
https://doaj.org/article/1f02bfdae7f64dd18535af7135bbe7e2
Written as a companion piece to complement Professor Eriksson's prior groundbreaking analysis, The Appearance of the Mythic Hero in the Twelve Seasons of Nature, this text, focusing on the heroine's experience, does more than just provide the other h
Autor:
Kalashnikovа A.A. Kalashnikovа, Rakitianskaya I.A. Rakitianskaya, City Polyclinic One Hundred Clinical Transfusiology, Riabova T.S. Riabova, Twelve, Saint Petersburg, Russia
Publikováno v:
Èpidemiologiâ i Infekcionnye Bolezni. Aktual’nye voprosy. :84-94
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3b931ac28d01a718ef883db74435912
https://doi.org/10.18565/epidem.2019.9.4.84-94
https://doi.org/10.18565/epidem.2019.9.4.84-94
Publikováno v:
TIME Magazine. 8/22/1988, Vol. 132 Issue 8, p30. 4p.